Amunix (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 05, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $73,000,000
Company Info
- Company Description
- Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.
- Market
- Cancer therapeutics
- Location
- Mountain View, California, USA
- Coinvestors
- Casdin Capital, Delian Capital, Frazier Healthcare Partners, Longitude Capital, Omega Funds, Polaris Partners, Redmile Group, Two River, Venrock